AR079710A1 - Proceso para el cultivo de celulas adherentes - Google Patents
Proceso para el cultivo de celulas adherentesInfo
- Publication number
- AR079710A1 AR079710A1 ARP100104895A AR079710A1 AR 079710 A1 AR079710 A1 AR 079710A1 AR P100104895 A ARP100104895 A AR P100104895A AR 079710 A1 AR079710 A1 AR 079710A1
- Authority
- AR
- Argentina
- Prior art keywords
- microcarriers
- cells
- cell
- cell population
- detach
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 238000004115 adherent culture Methods 0.000 title 1
- 230000001464 adherent effect Effects 0.000 abstract 2
- 230000002255 enzymatic effect Effects 0.000 abstract 2
- 239000001963 growth medium Substances 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 241000711798 Rabies lyssavirus Species 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 230000003321 amplification Effects 0.000 abstract 1
- 239000003124 biologic agent Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000003306 harvesting Methods 0.000 abstract 1
- 239000012678 infectious agent Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000003199 nucleic acid amplification method Methods 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0068—General culture methods using substrates
- C12N5/0075—General culture methods using substrates using microcarriers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0056—Xeno-free medium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
- C12N2500/92—Medium free of human- or animal-derived components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/99—Serum-free medium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20151—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Plant Pathology (AREA)
- Analytical Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0959472 | 2009-12-23 | ||
| FR1051754A FR2957355B1 (fr) | 2010-03-11 | 2010-03-11 | Procede de culture de cellules adherentes a des microporteurs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR079710A1 true AR079710A1 (es) | 2012-02-15 |
Family
ID=43709027
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP100104895 AR079710A1 (es) | 2009-12-23 | 2010-12-22 | Proceso para el cultivo de celulas adherentes |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9145543B2 (enExample) |
| EP (1) | EP2516623B1 (enExample) |
| JP (1) | JP5894929B2 (enExample) |
| KR (1) | KR101835100B1 (enExample) |
| CN (2) | CN102782121A (enExample) |
| AR (1) | AR079710A1 (enExample) |
| AU (1) | AU2010334723C1 (enExample) |
| BR (1) | BR112012015596B1 (enExample) |
| CA (1) | CA2784741A1 (enExample) |
| HK (1) | HK1243731A1 (enExample) |
| IL (1) | IL220167B (enExample) |
| MX (1) | MX2012007117A (enExample) |
| RU (1) | RU2612154C2 (enExample) |
| WO (1) | WO2011077035A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140271633A1 (en) * | 2013-03-14 | 2014-09-18 | Abbvie Inc. | Mammalian cell culture performance through surfactant supplementation of feed media |
| CN103289949A (zh) * | 2013-06-28 | 2013-09-11 | 四川省华派生物制药有限公司 | 一种从克氏瓶直接到生物反应器的细胞培养方法 |
| EP3778702B1 (en) | 2014-03-25 | 2023-06-28 | F. Hoffmann-La Roche AG | Methods of preparing a poloxamer for use in cell culture medium |
| ES2909630T3 (es) * | 2014-06-04 | 2022-05-09 | Amgen Inc | Métodos de recolección en cultivos de células de mamífero |
| EP3475410A4 (en) | 2016-06-24 | 2020-02-12 | Lonza Ltd | VARIABLE DIAMETER BIOREACTORS |
| CN106754672A (zh) * | 2016-11-30 | 2017-05-31 | 广州赛莱拉干细胞科技股份有限公司 | 一种贴壁细胞的培养方法 |
| CA3103570A1 (en) * | 2018-06-14 | 2019-12-19 | Abraham J And Phyllis Katz Cord Blood Foundation | Isolation of mesenchymal stromal cells from umbilical cord blood |
| WO2021181819A1 (ja) * | 2020-03-13 | 2021-09-16 | 昭和電工マテリアルズ株式会社 | 細胞懸濁液の製造方法、及び、接着細胞の製造方法 |
| BR112022024982A2 (pt) * | 2020-06-12 | 2022-12-27 | Biotech Foods S L | Processo e dispositivo para produção de carne de cultura |
| CN116036257B (zh) * | 2022-12-29 | 2024-11-15 | 瑞普（保定）生物药业有限公司 | 一种猪瘟活疫苗的制备方法 |
| WO2025125314A1 (fr) | 2023-12-11 | 2025-06-19 | Commissariat A L'energie Atomique Et Aux Energies Alternatives | Dispositif et procédé de culture cellulaire |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4664912A (en) | 1984-10-01 | 1987-05-12 | Wiktor Tadeusz J | Process for the large scale production of rabies vaccine |
| FR2635008B1 (fr) | 1988-08-05 | 1990-11-16 | Sanofi Sa | Agent activateur de la productivite specifique des cellules animales recombinantes a base de polyvinylpyrrolidone et milieu de culture defini le contenant |
| DK52393D0 (enExample) | 1993-05-05 | 1993-05-05 | Novo Nordisk As | |
| US5714375A (en) * | 1995-06-05 | 1998-02-03 | Nobl Laboratories, Inc. | Ileal symbiont intracellularis propagation in suspended host cells |
| ATE234631T1 (de) * | 1996-07-12 | 2003-04-15 | Aventis Pasteur | Immunisierungsverfahren in zwei schritten gegen pyramyxoviridae-viren unter verwendung abgeschwächter viraler stämme und preparation von proteinuntereinheiten |
| US6020182A (en) * | 1996-07-12 | 2000-02-01 | Connaught Laboratories Limited | Subunit respiratory syncytial virus vaccine preparation |
| US6168944B1 (en) * | 1997-01-31 | 2001-01-02 | Schering Corporation | Methods for cultivating cells and propagating viruses |
| SK285971B6 (sk) | 1997-12-24 | 2007-12-06 | Duphar International Research B. V. | Spôsob prípravy buniek na výrobu biologických materiálov |
| FR2801900B1 (fr) | 1999-12-03 | 2004-02-27 | Pasteur Merieux Serums Vacc | Methode de production de cellules animales adherentes |
| US6670184B2 (en) * | 2000-06-23 | 2003-12-30 | Basf Ag | Method for producing a lipid emulsion for use in insect cell culture |
| US6951752B2 (en) * | 2001-12-10 | 2005-10-04 | Bexter Healthcare S.A. | Method for large scale production of virus antigen |
| US6855535B2 (en) * | 2001-12-10 | 2005-02-15 | Baxter Healthcare S.A. | Method of large scale production of Hepatitis A virus |
| DE102004043256B4 (de) * | 2004-09-07 | 2013-09-19 | Rheinische Friedrich-Wilhelms-Universität Bonn | Skalierbarer Prozess zur Kultivierung undifferenzierter Stammzellen in Suspension |
| CN101265464B (zh) * | 2008-05-13 | 2010-06-16 | 中国人民解放军第二军医大学 | 一种猪骨髓内皮祖细胞的分离和培养方法 |
-
2010
- 2010-12-21 AU AU2010334723A patent/AU2010334723C1/en active Active
- 2010-12-21 WO PCT/FR2010/052850 patent/WO2011077035A1/fr not_active Ceased
- 2010-12-21 CN CN2010800645251A patent/CN102782121A/zh active Pending
- 2010-12-21 CN CN201710197964.3A patent/CN107460154A/zh active Pending
- 2010-12-21 EP EP10810863.0A patent/EP2516623B1/fr active Active
- 2010-12-21 CA CA2784741A patent/CA2784741A1/fr not_active Abandoned
- 2010-12-21 RU RU2012130928A patent/RU2612154C2/ru active
- 2010-12-21 BR BR112012015596-2A patent/BR112012015596B1/pt active IP Right Grant
- 2010-12-21 MX MX2012007117A patent/MX2012007117A/es active IP Right Grant
- 2010-12-21 JP JP2012545386A patent/JP5894929B2/ja active Active
- 2010-12-21 KR KR1020127018857A patent/KR101835100B1/ko active Active
- 2010-12-22 US US12/976,679 patent/US9145543B2/en active Active
- 2010-12-22 AR ARP100104895 patent/AR079710A1/es active IP Right Grant
-
2012
- 2012-06-04 IL IL220167A patent/IL220167B/en active IP Right Grant
-
2018
- 2018-03-05 HK HK18103103.8A patent/HK1243731A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1243731A1 (zh) | 2018-07-20 |
| AU2010334723A1 (en) | 2012-07-12 |
| BR112012015596B1 (pt) | 2021-06-01 |
| CN107460154A (zh) | 2017-12-12 |
| WO2011077035A1 (fr) | 2011-06-30 |
| CA2784741A1 (fr) | 2011-06-30 |
| BR112012015596A2 (pt) | 2015-11-03 |
| KR101835100B1 (ko) | 2018-03-08 |
| RU2012130928A (ru) | 2014-01-27 |
| MX2012007117A (es) | 2012-07-23 |
| IL220167A0 (en) | 2012-07-31 |
| US20110151506A1 (en) | 2011-06-23 |
| EP2516623A1 (fr) | 2012-10-31 |
| JP2013515473A (ja) | 2013-05-09 |
| US9145543B2 (en) | 2015-09-29 |
| RU2612154C2 (ru) | 2017-03-02 |
| JP5894929B2 (ja) | 2016-03-30 |
| EP2516623B1 (fr) | 2016-10-05 |
| AU2010334723B2 (en) | 2015-02-05 |
| KR20120102788A (ko) | 2012-09-18 |
| CN102782121A (zh) | 2012-11-14 |
| AU2010334723C1 (en) | 2015-05-28 |
| IL220167B (en) | 2018-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR079710A1 (es) | Proceso para el cultivo de celulas adherentes | |
| EA201270173A1 (ru) | Получение полиовируса с высокими титрами для получения вакцины | |
| EA200801221A1 (ru) | Вирусные вакцины, полученные из клеток, с низкими уровнями остаточной клеточной днк | |
| JP2019520844A5 (enExample) | ||
| WO2013039861A3 (en) | Engineered nucleic acids and methods of use thereof | |
| AU2007240448A8 (en) | Methods and compositions for expressing negative-sense viral RNA in canine cells | |
| MY151119A (en) | Duck embryonic derived stem cell lines for the production of viral vaccines | |
| DE60139026D1 (de) | Lebender influenza impfstoff und verfahren zu seiner herstellung | |
| MXPA05009096A (es) | Metodo de cultivo celular libre de animal. | |
| WO2011082388A3 (en) | Infectious dna vaccines against chikungunya virus | |
| ATE469972T1 (de) | Multiplasmid-system zur erzeugung des grippevirus | |
| HK1204275A1 (en) | Method for the preparation of dendritic cell vaccines | |
| CN103275925A (zh) | 鳜鱼脑细胞系的构建方法 | |
| AR034216A1 (es) | Metodo de extraccion de virus a partir de cultivos celulares y composiciones que comprenden dicho virus | |
| MX387420B (es) | Producción de virus en cultivos celulares. | |
| CN103232969B (zh) | 一种对虾细胞培养基 | |
| CN104974977B (zh) | 一种鞍带石斑鱼肾组织细胞系及其构建方法 | |
| CL2008003821A1 (es) | Metodo para producir el virus de la estomatitis vesicular (vsv) atenuado en celulas, que comprende: a) proporcionar una celula que comprende un gen g vsv optimizado e inducible, b) inducir la celula a expresar dicho gen, c) infectar la celula con un vsv atenuado, d) hacer crecer dichas celulas, y e) recuperar el vsv atenuado | |
| AR043862A1 (es) | Procedimiento para la obtencion de estirpes celulares de mastocitos a partir de tejidos de cerdo y procedimiento para la produccion de moleculas de tipo de la heparina | |
| BRPI0914805B8 (pt) | método para replicar vírus em uma cultura de células scldk, processo para adaptar células cldk dependentes do substrato para desenvolvimento em suspensão, método para propagar continuamente células scldk em suspensão, e, composição | |
| AR076924A1 (es) | Vacuna contra la encefalitis japonesa y metodo de elaboracion de la misma | |
| DOP2024000204A (es) | Composiciones y métodos para la prevención y el tratamiento de la infección por el virus de la rabia | |
| EA200701129A1 (ru) | Бактериальные упаковывающие штаммы, используемые для генерирования и продуцирования рекомбинантных нуклеокапсидов с двухцепочечной рнк и их применение | |
| EP4410970A3 (en) | Efficient cell culture system for hepatitis c virus genotype 6a | |
| JP2010265270A5 (enExample) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |